Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.

Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, Berry CE, Barouch LA, Vandegaer KM, Li D, Hare JM.

Circ Res. 2006 Feb 3;98(2):271-9. Epub 2005 Dec 15. Erratum in: Circ Res. 2006 May 12;98(9):e70. Barouch, Lili A [added].

2.

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium.

Kögler H, Fraser H, McCune S, Altschuld R, Marbán E.

Cardiovasc Res. 2003 Sep 1;59(3):582-92.

4.

NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction.

Isabelle M, Vergeade A, Moritz F, Dautréaux B, Henry JP, Lallemand F, Richard V, Mulder P, Thuillez C, Monteil C.

J Mol Cell Cardiol. 2007 Feb;42(2):326-32. Epub 2007 Jan 10.

PMID:
17217956
5.

Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.

Kang SM, Lim S, Song H, Chang W, Lee S, Bae SM, Chung JH, Lee H, Kim HG, Yoon DH, Kim TW, Jang Y, Sung JM, Chung NS, Hwang KC.

Eur J Pharmacol. 2006 Mar 27;535(1-3):212-9. Epub 2006 Mar 6.

PMID:
16516885
6.

Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.

Tan Z, Dai T, Zhong X, Tian Y, Leppo MK, Gao WD.

Eur J Pharmacol. 2009 Oct 25;621(1-3):71-7. doi: 10.1016/j.ejphar.2009.08.033. Epub 2009 Sep 6.

PMID:
19737552
7.

Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat.

Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S.

Hypertension. 2007 Oct;50(4):657-62. Epub 2007 Aug 20.

8.
9.

Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.

Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T, Spinale FG.

Circulation. 2001 May 8;103(18):2303-9.

10.

Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.

Doerries C, Grote K, Hilfiker-Kleiner D, Luchtefeld M, Schaefer A, Holland SM, Sorrentino S, Manes C, Schieffer B, Drexler H, Landmesser U.

Circ Res. 2007 Mar 30;100(6):894-903. Epub 2007 Mar 1.

11.

Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure.

Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, Stewart G, Fitton T, Minhas KM, Brawn J, Hare JM.

J Mol Cell Cardiol. 2005 Sep;39(3):531-6.

PMID:
15963530
12.

Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters.

Hayashi K, Kimata H, Obata K, Matsushita A, Fukata A, Hashimoto K, Noda A, Iwase M, Koike Y, Yokota M, Nagata K.

J Card Fail. 2008 Apr;14(3):238-44. doi: 10.1016/j.cardfail.2007.11.001.

PMID:
18381188
13.

The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.

Anderson KM, Eckhart AD, Willette RN, Koch WJ.

Hypertension. 1999 Jan;33(1 Pt 2):402-7.

14.

Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats.

Laakso JT, Teräväinen TL, Martelin E, Vaskonen T, Lapatto R.

J Hypertens. 2004 Jul;22(7):1333-40.

PMID:
15201549
15.

The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.

Cingolani HE, Plastino JA, Escudero EM, Mangal B, Brown J, Pérez NG.

J Card Fail. 2006 Sep;12(7):491-8.

PMID:
16952781
16.

Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.

Cittadini A, Monti MG, Isgaard J, Casaburi C, Strömer H, Di Gianni A, Serpico R, Saldamarco L, Vanasia M, Saccà L.

Cardiovasc Res. 2003 Jun 1;58(3):555-64.

17.

Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts.

Naumova AV, Chacko VP, Ouwerkerk R, Stull L, Marbán E, Weiss RG.

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H837-43. Epub 2005 Sep 23.

18.

Pulmonary oxidative stress, inflammation, and dysregulated iron homeostasis in rat models of cardiovascular disease.

Shannahan JH, Schladweiler MC, Richards JH, Ledbetter AD, Ghio AJ, Kodavanti UP.

J Toxicol Environ Health A. 2010;73(10):641-56. doi: 10.1080/15287390903578208.

PMID:
20391109
19.

Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats.

Umemoto S, Tanaka M, Kawahara S, Kubo M, Umeji K, Hashimoto R, Matsuzaki M.

Hypertens Res. 2004 Nov;27(11):877-85.

20.

Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats.

Norton GR, Veliotes DG, Osadchii O, Woodiwiss AJ, Thomas DP.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H372-8. Epub 2007 Nov 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk